|
End-of-day quote
Shanghai S.E.
2026-09-22
|
5-day change | 1st Jan Change | ||
| 17.75 CNY | -1.11% |
|
-2.74% | +0.74% |
EPS & Dividend: DaShenLin Pharmaceutical Group Co., Ltd.
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Dividend per Share 2 | 0.3472 | 0.5 | 0.31 | 0.31 | 0.49 | 0.9418 | 1.043 | 1.222 |
| Rate of return | 1.19% | 1.52% | 1.24% | 2.06% | 2.78% | 5.31% | 5.88% | 6.88% |
| EPS 2 | 0.6944 | 0.9083 | 1.03 | 0.81 | 1.08 | 1.304 | 1.5 | 1.701 |
| Distribution rate | 50% | 55% | 30.1% | 38.3% | 45.4% | 72.2% | 69.5% | 71.8% |
| Reference price 2 | 29.24 | 33.00 | 24.90 | 15.06 | 17.62 | 17.75 | 17.75 | 17.75 |
| Nbr of stocks (in thousands) | 1,138,968 | 1,138,947 | 1,138,902 | 1,138,848 | 1,138,848 | 1,138,855 | - | - |
| Announcement Date | 4/27/22 | 4/27/23 | 4/28/24 | 4/25/25 | 4/23/26 | - | - | - |
1CNY in Million2CNY
Estimates
Past dividends: DaShenLin Pharmaceutical Group Co., Ltd.
| 2026-06-26 | Ex-dividend date - 0.49 CNY | 00:00 |
| 2025-11-06 | Ex-dividend date - 0.34 CNY | 00:00 |
| Dividend Yield (Y) | Dividend Yield (Y+1) | P/E (Y) | Price to Book (Y) | EV / Sales (Y) | ||
|---|---|---|---|---|---|---|
 | 5.25% | 5.81% | 13.77x | 2.61x | 0.58x | |
| -.--% | -.--% | 16.53x | 1.49x | 0.66x | |
| 2.28% | 2.61% | 16.37x | 1.69x | 0.73x | |
| 1.1% | 1.46% | 19.47x | 2.17x | 0.73x | |
| 2.96% | 3.38% | 14.26x | 2.11x | 0.87x | |
| 5.58% | 6.13% | 14.5x | 4.37x | 1.24x | |
| 4.53% | 4.98% | 14.33x | 6.43x | 0.86x | |
| - | - | 35.98x | - | - | |
| - | - | - | - | 0.25x | |
| - | - | - | - | - | |
| Average | 3.1% | 3.48% | 18.15x | 2.98x | 0.74x | |
| Weighted average by Cap. | 1.99% | 2.26% | 17.47x | 2.36x | 0.73x |
Year-on-year evolution of the Yield
Dividend / Share (DPS) - Evolution of Analysts' Estimates
Dividend / Share (DPS) - Estimates Revisions
Earnings Per Share (EPS) - Evolution of Analysts' Estimates
Annual Profit -
Select your edition
All financial news and data tailored to specific country editions
